Mavrilimumab
- Generic Name
- Mavrilimumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1085337-57-0
- Unique Ingredient Identifier
- 1158JD1P9A
- Background
Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
- Associated Conditions
- -
- Associated Therapies
- -
Biotechnology Market Size to Reach USD 5.68 Trillion by 2033
The global biotechnology market, valued at USD 1.54 Trillion in 2023, is projected to reach USD 5.68 Trillion by 2033, growing at a CAGR of 13.95%. Growth is driven by government support, personalized medicine, COVID-19 vaccine development, agricultural biotech applications, and advancements in gene editing and synthetic biology. North America leads the market, while Asia Pacific is expected to grow the fastest.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath